◀ Back to APOB
APOB — CD36
Pathways - manually collected, often from reviews:
-
Reactome Reaction:
APOB
→
CD36
(indirect_complex)
Boullier et al., J Biol Chem 2000*, Podrez et al., J Clin Invest 2000*, Janabi et al., Arterioscler Thromb Vasc Biol 2000*, Bodart et al., Circ Res 2002*, Podrez et al., J Biol Chem 2002*, Zeng et al., J Biol Chem 2003*, Hoebe et al., Nature 2005*, Laugerette et al., J Clin Invest 2005*, Greenberg et al., J Exp Med 2006*, Sun et al., J Lipid Res 2007*, Nilsen et al., J Leukoc Biol 2008*, McDermott-Roe et al., Biosci Rep 2008*, Means et al., J Exp Med 2009*, Collins et al., J Biol Chem 2009*, Ren et al., J Exp Med 1995*, Endemann et al., J Biol Chem 1993*, Abumrad et al., J Biol Chem 1993*, Fadok et al., J Immunol 1998*
-
Reactome Reaction:
APOB
→
CD36
(reaction)
Boullier et al., J Biol Chem 2000*, Podrez et al., J Clin Invest 2000*, Janabi et al., Arterioscler Thromb Vasc Biol 2000*, Bodart et al., Circ Res 2002*, Podrez et al., J Biol Chem 2002*, Hoebe et al., Nature 2005*, Laugerette et al., J Clin Invest 2005*, Greenberg et al., J Exp Med 2006*, Means et al., J Exp Med 2009*, Ren et al., J Exp Med 1995*, Endemann et al., J Biol Chem 1993*, Abumrad et al., J Biol Chem 1993*, Fadok et al., J Immunol 1998*
Text-mined interactions from Literome
Yamaguchi et al., Thromb Res 2000
(Thrombasthenia) :
Oxidized-LDL dose-dependently
inhibited bindings of both GS95 and OKM5 antibodies to platelet
CD36 , while PS-liposome inhibited the binding of GS95 but not OKM5 or FA6-152
Feng et al., J Lipid Res 2000
:
Induction of
CD36 expression by oxidized
LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma
Wintergerst et al., Eur J Biochem 2000
:
Here we present evidence that
CD36 is
involved in oxidized
LDL ( OxLDL ) -induced apoptosis in human monocyte derived macrophages
Ishii et al., Circ Res 2004
(Arteriosclerosis) :
Role of Nrf2 in the
regulation of
CD36 and stress protein expression in murine macrophages : activation by oxidatively modified
LDL and 4-hydroxynonenal
Jostarndt et al., Biochem Pharmacol 2004
:
Since free oxidized polyunsaturated fatty acids are PPARgamma ligands, we studied the
effects of
LDL modified by the simultaneous action of sPLA2 and 15-lipoxygenase ( 15LO ) on
CD36 expression and PPARgamma activation in monocytic cells ... Importantly,
LDL modified by sPLA2 and 15LO did not efficiently
induce upregulation
CD36 in PPARgamma-deficient macrophage differentiated embryonic stem cells confirming a role of PPARgamma in CD36 expression in cells stimulated with enzLDL ... Our data show that
LDL modified with physiologically relevant enzymes
stimulates CD36 expression in non differentiated monocytes and that this process involves PPARgamma activation
Koller et al., Pathophysiol Haemost Thromb 2006
:
The
role of
CD36 in platelet binding by oxidised
LDL is well established, although additional receptors may exist
Graessler et al., Diabetologia 2007
(Glucose Intolerance) :
Glycoxidised
LDL isolated from subjects with impaired glucose tolerance
increases CD36 and peroxisome proliferator-activator receptor gamma gene expression in macrophages
Luangrath et al., Arterioscler Thromb Vasc Biol 2008
:
Our objective was to define the physiological
role of
CD36 in both native
LDL and oxLDL metabolism in mice
Maruyama et al., Arch Biochem Biophys 2008
:
We previously demonstrated that Nrf2 regulates oxidized
LDL mediated
CD36 expression in macrophages
Pedrosa et al., Biochim Biophys Acta 2010
:
These results provide evidence that
CD36 expression
induced by
LDL ( - ) is Nrf2 dependent
Granados-Principal et al., Mol Nutr Food Res 2012
(Atherosclerosis) :
SQ caused a dose dependent reduction of
CD36 in the
presence of native and moderate
LDL in monocytes and macrophages
Babaahmadi Rezaei et al., Iran Biomed J 2013
:
Compare the
Effect of Eicosapentaenoic Acid and Oxidized Low-Density
Lipoprotein on the Expression of
CD36 and Peroxisome Proliferator Activated Receptor Gamma ... Conclusion : It was confirmed that both EPA and
ox-LDL increased
CD36 expression but not PPAR-?, and also co-treatment with PPAR-? inhibitor decreased CD36 expression
Endemann et al., J Biol Chem 1993
:
CD36 may
play a role in scavenging
LDL modified by oxidation and may mediate effects of OxLDL on monocytes and platelets in atherosclerotic lesions